Learn more

DABUR RES FOUNDATION

Overview
  • Total Patents
    141
About

DABUR RES FOUNDATION has a total of 141 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are EKWURIBE NNOCHIRI N, NICOX SCIENCE IRELAND and JOLLA PHARMA.

Patent filings per year

Chart showing DABUR RES FOUNDATIONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mukherjee Rama 72
#2 Burman Anand C 64
#3 Jaggi Manu 58
#4 Singh Anu T 53
#5 Prasad Sudhanand 42
#6 Ramadoss Sunder 24
#7 Khattar Dhiraj 20
#8 Mathur Archna 18
#9 Kumar Mukesh 15
#10 Duggal Ramesh Kumar 12

Latest patents

Publication Filing date Title
WO2005121143A1 Flavopereirine derivatives for cancer therapy
US2004171560A1 Stabilized pharmaceutical composition
US2005032707A1 Peptides comprising furanoid sugar amino acids for the treatment of cancer
US2005020666A1 Cardioprotective agents
US2005016926A1 Stabilized formulation
US2004220197A1 Hydroanthracene based compounds as anticancer agents
US2004121950A1 Drug comprising synthetic peptide analogs for the treatment of cancer
EP1581471A1 Cyclopentenone derivatives for cancer therapy
US2004116394A1 Method for treating cancer using betulinic acid rich herbal extract
US2003229146A1 Cyclopentenone derivatives for cancer therapy
WO2004032972A1 An oral formulation of methylglyoxal and its imino acid conjugates for human use
WO2004024145A1 Anti-cancer activity of carvedilol and its isomers
US6632832B1 Anti-cancer activity of carvedilol and its isomers
AU2002321882A1 Multivalent synthetic vaccine for cancer
US2003087951A1 Oral formulation of methylglyoxal and its imino acid conjugates for human use
US2003118627A1 Anticancer activity of imino acid conjugates or methylglyoxal
US2003105009A1 Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
ZA200201947B Novel betulinic acid derivatives having antiangiogenic activity process for producing such derivatives and their use for treating tumor associated angiogenesis.
KR20030005484A A herbal composition and a process for the manufacture of such composition for management of gynaecological disorders
MY117747A Vasoactive intestinal peptide analogs